Treating Rheumatoid Arthritis in Zanzibar: a cost effectiveness study comparing conventional, biologic, and targeted-synthetic disease modifying anti-rheumatic drugs
View ORCID ProfileSanaa S. Said, Melf-Jakob Kühl, View ORCID ProfileBjorg-Tilde Svanes Fevang, Tone Wikene Nystad, View ORCID ProfileKjell Arne Johansson
doi: https://doi.org/10.1101/2023.12.05.23299489
Sanaa S. Said
1School of Health and Medical Sciences, The State University of Zanzibar, Zanzibar, Tanzania
2Bergen Center for Ethics and Priority Settings (BCEPS), Department of Global Public Health and Primary Care, Bergen, Norway
3University of Bergen, Department of Clinical Science, Haukeland University Hospital, Bergen, Norway
4Haukeland University Hospital, Department of International Collaboration (DIC), Bergen, Norway
5Mnazi Mmoja Hospital, Department of Internal Medicine, Zanzibar, Tanzania
Melf-Jakob Kühl
6Centre for International Health (CIH), Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
7Health Economics Leadership and Translational Ethics Research Group (HELTER), Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
Bjorg-Tilde Svanes Fevang
3University of Bergen, Department of Clinical Science, Haukeland University Hospital, Bergen, Norway
8Haukeland University Hospital, Department of Rheumatology, Bergen, Norway
Tone Wikene Nystad
8Haukeland University Hospital, Department of Rheumatology, Bergen, Norway
Kjell Arne Johansson
2Bergen Center for Ethics and Priority Settings (BCEPS), Department of Global Public Health and Primary Care, Bergen, Norway
9Haukeland University Hospital, Department of Addictive Medicine, Bergen, Norway

Article usage
Posted December 06, 2023.
Treating Rheumatoid Arthritis in Zanzibar: a cost effectiveness study comparing conventional, biologic, and targeted-synthetic disease modifying anti-rheumatic drugs
Sanaa S. Said, Melf-Jakob Kühl, Bjorg-Tilde Svanes Fevang, Tone Wikene Nystad, Kjell Arne Johansson
medRxiv 2023.12.05.23299489; doi: https://doi.org/10.1101/2023.12.05.23299489
Treating Rheumatoid Arthritis in Zanzibar: a cost effectiveness study comparing conventional, biologic, and targeted-synthetic disease modifying anti-rheumatic drugs
Sanaa S. Said, Melf-Jakob Kühl, Bjorg-Tilde Svanes Fevang, Tone Wikene Nystad, Kjell Arne Johansson
medRxiv 2023.12.05.23299489; doi: https://doi.org/10.1101/2023.12.05.23299489
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)